Carregant...
Pharmacological Inhibition of CB(1) Cannabinoid Receptor Protects Against Doxorubicin-Induced Cardiotoxicity
OBJECTIVES: We aimed to explore the effects of pharmacologic inhibition of cannabinoid-1 (CB(1)) receptor in in vivo and in vitro models of doxorubicin (DOX)-induced cardiotoxicity. BACKGROUND: Doxorubicin is one of the most potent antitumor agents available; however, its clinical use is limited bec...
Guardat en:
| Autors principals: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2239316/ https://ncbi.nlm.nih.gov/pubmed/17678736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2007.03.057 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|